With executive leadership expertise in diverse health care companies, Scott Storrer currently guides the personalized medicine enterprise Genomind as its founding CEO. His company offers behavioral health clinicians and patients with molecular diagnostic tests that help evaluate brain wellness. The primary product of Scott Storrer’s firm is the saliva-based genetic test Genecept Assay, which helps professionals make treatment decisions for patients with psychiatric conditions such as depression.
Mr. Storrer completed his bachelor’s degree in economics and mathematics at Depauw University and his master of business administration at a branch of Boston University in Kobe, Japan. Throughout much of the 1990s, he was a senior vice president with Liberty Mutual Group in Boston and led revenue growth in the supplemental health and life insurance business. Mr. Storrer also served as group president of the pharmaceutical segment of Cardinal Health, a Fortune 100 company. Although he took on the job at a time when the industry was in a major downturn and his pharmaceutical group was underperforming, Scott Storrer nevertheless successfully engineered a turnaround